TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Otsuka Pharma Scandinavia AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
339,222
|
304,312
|
278,005 |
Financial expenses |
3
|
35
|
200 |
Earnings before taxes |
9,230
|
11,136
|
8,998 |
EBITDA |
8,990
|
11,485
|
9,640 |
Total assets |
133,647
|
114,766
|
100,728 |
Current assets |
132,954
|
114,287
|
100,190 |
Current liabilities |
83,993
|
66,316
|
52,597 |
Equity capital |
49,654
|
48,450
|
48,131 |
- share capital |
101
|
95
|
98 |
Employees (average) |
38
|
35
|
36 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
37.2%
|
42.2%
|
47.8% |
Turnover per employee |
8,927
|
8,695
|
7,722 |
Profit as a percentage of turnover |
2.7%
|
3.7%
|
3.2% |
Return on assets (ROA) |
6.9%
|
9.7%
|
9.1% |
Current ratio |
158.3%
|
172.3%
|
190.5% |
Return on equity (ROE) |
18.6%
|
23.0%
|
18.7% |
Change turnover |
13,316
|
34,663
|
-13,356 |
Change turnover % |
4%
|
13%
|
-5% |
Chg. No. of employees |
3
|
-1
|
-6 |
Chg. No. of employees % |
9%
|
-3%
|
-14% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.